Fundraising Fox
🦊/People
Sign in

Stanford Peng

Investor

Venture Partner at Frazier Life Sciences · Board director at Alpine Immune Sciences

Seattle

Find your path to Stanford

207 people in our graph share verified history with Stanford — schools, employers, funds. One of them is your warm intro.

René KuijtenunlockedStanford: together at University of Pennsylvania School of Medicine
×8Stanford: together at Yale School of Medicine
×3Stanford: together at University of Pennsylvania School of Medicine

About

Stanford Peng is a Venture Partner at Frazier Life Sciences, where he works on company creation, joining the firm in 2025. A physician-scientist and R&D executive with over 25 years of drug development and biomedical research experience, he most recently served as President and Head of R&D at Alpine Immune Sciences, which was acquired by Vertex Pharmaceuticals. He has previously held roles at Stemcentrx, Seagen, Roche, Benaroya Research Institute, and Washington University in St. Louis, and continues to practice as a rheumatologist.

Invests in

Biotech

Board director at Alpine Immune Sciences

Intro paths

→

In turn, Stanford can intro founders to Alpine Immune Sciences's investors below.

Alpine Immune Sciences's investors · 4

Biotechnology Value FundSan Francisco · since 2021Decheng CapitalMenlo Park · since 2021Frazier Life SciencesPalo Alto · since 2021OrbiMedNew York · $1M – $75M checks · since 2021

Co-founders at Alpine Immune Sciences

MG
Mitchell GoldExecutive Chairman and Chief Executive Officer

Experience

  1. Frazier Life SciencesVenture Partnercurrent2025 — present
  2. Alpine Immune Sciences (acquired by Vertex Pharmaceuticals)President and Head of Research & Development2016 — 2024
  3. Stemcentrx, Inc. (acquired by Abbvie)Chief Medical Officer2015 — 2016

Skills & more

Lifesciences15Rheumatology31
  • Registered in Musculoskeletal (RMSK) Sonography — American Registry for Diagnostic Medical Sonography
  • Internal Medicine — American Board of Internal Medicine

From Stanford's professional profile.

Colleagues at Frazier Life Sciences

Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences

Frequently asked questions

Who is Stanford Peng?
Stanford Peng is a Venture Partner at Frazier Life Sciences, where he works on company creation, joining the firm in 2025. A physician-scientist and R&D executive with over 25 years of drug development and biomedical research experience, he most recently served as President and Head of R&D at Alpine Immune Sciences, which was acquired by Vertex Pharmaceuticals. He has previously held roles at Stemcentrx, Seagen, Roche, Benaroya Research Institute, and Washington University in St. Louis, and continues to practice as a rheumatologist.
Where does Stanford Peng work?
Stanford Peng is Venture Partner at Frazier Life Sciences and Board director at Alpine Immune Sciences.
What does Stanford Peng invest in?
Stanford Peng invests in Biotech.
Where did Stanford Peng go to school?
Stanford Peng studied at Brigham and Women's Hospital (Fellowship, Rheumatology); University of Pennsylvania School of Medicine (Residency, Internal Medicine); Yale School of Medicine (MD, PhD, Medicine, Biology).

Same school